1
项与 CD19/BCMA CAR-T (Suzhou Maoxing Biotechnology) 相关的临床试验Single-arm, single-center, open-label clinical study for CD19-BCMA chimeric antigen receptor T cell infusions for patients with positive CD19, BCMA relapse or refractory multiple myeloma
100 项与 CD19/BCMA CAR-T (Suzhou Maoxing Biotechnology) 相关的临床结果
100 项与 CD19/BCMA CAR-T (Suzhou Maoxing Biotechnology) 相关的转化医学
100 项与 CD19/BCMA CAR-T (Suzhou Maoxing Biotechnology) 相关的专利(医药)
100 项与 CD19/BCMA CAR-T (Suzhou Maoxing Biotechnology) 相关的药物交易